Synthesis, anticancer activity, and β‐lactoglobulin binding interactions of multitargeted kinase inhibitor sorafenib tosylate (SORt) using spectroscopic and molecular modelling approaches-Reference-Cited by-同舟云学术

Synthesis, anticancer activity, and β‐lactoglobulin binding interactions of multitargeted kinase inhibitor sorafenib tosylate (SORt) using spectroscopic and molecular modelling approaches

Published:2020-08-12 Issue:1 Volume:36 Page:117-128
ISSN:1522-7235
Container-title:Luminescence
language:en
Short-container-title:Luminescence

Author:

Tanzadehpanah Hamid¹,Bahmani Asrin¹,Hosseinpour Moghadam Neda¹,Gholami Hamid²,Mahaki Hanie¹,Farmany Abbas³,Saidijam Massoud¹^ORCID

Affiliation:

1. Research Center for Molecular Medicine Hamadan University of Medical Sciences Hamadan Iran

2. Department of Biochemistry, School of Medicine Hamadan University of Medical Sciences Hamadan Iran

3. Dental Research Center, School of Dentistry Hamadan University of Medical Sciences Hamadan Iran

Publisher

Wiley

Subject

Chemistry (miscellaneous),Biophysics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bio.3929

Reference44 articles.

1. Cancer statistics, 2019

2. Design, synthesis and biological activities of sorafenib derivatives as antitumor agents

3. Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors

4. The Role of the Breast Cancer Resistance Protein (ABCG2) in the Distribution of Sorafenib to the Brain

5. Biophysical study on complex formation between β-Lactoglobulin and vitamin B12

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Key target genes related to anti-breast cancer activity of ATRA: A network pharmacology, molecular docking and experimental investigation;Heliyon;2024-07

2. Pro-inflammatory responses after peptide-based cancer immunotherapy;Heliyon;2024-06

3. MicroRNAs Regulate Inhibitor of Apoptosis Proteins (IAPs) in Colorectal Cancer;MicroRNA;2023-11

4. Nanoparticles Containing Oxaliplatin and the Treatment of Colorectal Cancer;Current Pharmaceutical Design;2023-10

5. BBOX1-AS1: A novel oncogenic long non-coding RNA in human cancers;Pathology - Research and Practice;2023-10